Latest GMOs Publications
How to make a representation for G0493-01
Year: 2013
How to make a representation to the EPA about the proposed Deliberate Release G0493
Board Minute Extract re decision on modified condition
Year: 2013
An extract from the Board Minute of the meeting of 10 June 2013,approving the modification of Condition 6.8
G0493-01 Valid representations received from members of the public
Representations received from members of the public in response to Intervet International BV's notification, June 2013
Year: 2013
The following valid representations were submitted in response to the notification by Intervet International BV, seeking consent to carry out a veterinary trial using a genetically modified vaccine
Non-confidential Annex List G0493
Year: 2013
List of non-confidential annexes received as part of Merck Sharp and Dohme/Intervet International BV's application G0493
G0493-01 Consent Conditions
Year: 2013
G0493-01 Consent Conditions issued to Intervet International BV on 10 April 2013 for veterinary trial using a genetically modified vaccine
Board minute extract for Agency Board Meeting of 9 April 2013
Year: 2013
An extract from the minutes of the EPA Board Meeting of 9 April 2013, at which Intervet International BV's notification seeking consent to carry out a veterinary trial at Belmont Stud, Co Offaly, was discussed.
GM equine vaccine Equilis RhodE application
Year: 2013
Non-confidential application documentation for Merck Sharp and Dohme application on behalf of Intervet International BV for consent to carry out a clinical study with a GM vaccine
Requests for further information, and responses received
Year: 2013
Requests from the Agency to the notifier for additional information, and the responses received, including an amended SNIF.
GMO Register G0498-01
Year: 2013
The GMO Register entry provides significant details of the clinical trial
Environmental Risk Assessment Dossier
Year: 2013
Environmental Risk Assessment Dossier for Clinical Trial G0498-01
Requests for further information and replies
Year: 2013
Requests from the Agency to the notifier for additional information, and the responses received.
Technical Dossier Non-Confidential
Year: 2013
Environmental Risk Assessment Dossier (in accordance with Schedule II, SI 500 of 2003) for proposed Clinical Trial G0498-01
Part D Conclusions G0498-01
Year: 2013
Conclusions on the potential environmental impact from the release or the placing on the market of genetically modified organisms, re G0498-01
G0498-01 Inspector's Report
Year: 2013
All documentation submitted in respect of this notification was taken into consideration by the EPA Inspector in her report to the Board of the Agency
Board Minute Extract of 25 June 2013
Year: 2013
An extract from the minutes of the EPA Board Meeting of 25 June 2013 at which the Centre for Cellular and Molecular Therapeutics' notification seeking consent to carry out a clinical trial at St James's Hospital Dublin was discussed
G0498-01 Consent Conditions
Year: 2013
G0498-01 Consent Condition issued to The Centre for Cellular and Molecular Therapeutics at the Children's Hospital of Philadelphia, USA, on 3 July 2013 for a clinical trial using a Genetically Modified Organism (GMO) at St. James's Hospital Dublin
Summary Notification Information Format G0498-01
Year: 2013
Summary Notification Information Format for proposed Clinical Trial G0498-01
Response from Teagasc 14 June 2012
Year: 2013
Correspondence from Teagasc regarding 4 April 2012 and 23 May 2012 requests for further information
Response from Teagasc 11 April Part 2
Year: 2013
Teagasc's response, dated 11 April 2012, to EPA's request for further information, Part 2